Close Menu

NEW YORK – Invitae said this week that it completed its previously announced acquisition of Clear Genetics on Nov. 12 for approximately $50 million, about half of which was paid in cash and half in Invitae common stock. The company is now a wholly owned subsidiary of Invitae.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The New York Times reports on an effort to address in high school biology classes misconceptions regarding race and genetics.

60 Minutes speaks with Harvard's George Church about tackling the effects of aging and more.

In PLOS this week: rare alterations in Timothy syndrome, analysis of twins' gut microbiomes, and more.

GenomeWeb reports that Veritas Genetics is suspending its US operations.